• Je něco špatně v tomto záznamu ?

Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries

M. Haluzik, A. Kretowski, K. Strojek, L. Czupryniak, A. Janez, P. Kempler, M. Andel, T. Tankova, M. Boyanov, L. Smircic Duvnjak, L. Madacsy, I. Tarnowska, M. Zychma, N. Lalic,

. 2018 ; 9 (2) : 727-741. [pub] 20180309

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18009944

INTRODUCTION: The aim of this study was to determine the level of awareness of hypoglycemia, the level of fear for hypoglycemia, and the response to hypoglycemic events among insulin-treated diabetes patients from Central and Eastern Europe (CEE). The impact of hypoglycemia on the use of healthcare resources and patient productivity was also assessed. METHODS: This was a multicenter, non-interventional, two-part, patient self-reported questionnaire study that comprised both a retrospective cross-sectional evaluation and a prospective observational evaluation. Study participants were insulin-treated adult patients with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) from CEE. RESULTS: Most patients (85.4% T1DM and 83.6% T2DM) reported normal hypoglycemia awareness. The median hypoglycemia fear score was 5 out of 10 for T1DM and 4 out of 10 for T2DM patients. Patients increased glucose monitoring, consulted a doctor/nurse, and/or reduced the insulin dose in response to hypoglycemia. As a consequence of hypoglycemia, patients took leave from work/studies or arrived late and/or left early. Hospitalization was required for 31 (1.2%) patients with T1DM and 66 (2.1%) patients with T2DM. CONCLUSION: Hypoglycemia impacts patients' personal and social functioning, reduces productivity, and results in additional costs, both direct (related to increased use of healthcare resources) and indirect (related to absenteeism. FUNDING: Novo Nordisk.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18009944
003      
CZ-PrNML
005      
20180405101854.0
007      
ta
008      
180404s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s13300-018-0388-2 $2 doi
035    __
$a (PubMed)29524189
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Haluzik, Martin $u Diabetes Centre and Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21, Prague 4, Czech Republic. halm@ikem.cz.
245    10
$a Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries / $c M. Haluzik, A. Kretowski, K. Strojek, L. Czupryniak, A. Janez, P. Kempler, M. Andel, T. Tankova, M. Boyanov, L. Smircic Duvnjak, L. Madacsy, I. Tarnowska, M. Zychma, N. Lalic,
520    9_
$a INTRODUCTION: The aim of this study was to determine the level of awareness of hypoglycemia, the level of fear for hypoglycemia, and the response to hypoglycemic events among insulin-treated diabetes patients from Central and Eastern Europe (CEE). The impact of hypoglycemia on the use of healthcare resources and patient productivity was also assessed. METHODS: This was a multicenter, non-interventional, two-part, patient self-reported questionnaire study that comprised both a retrospective cross-sectional evaluation and a prospective observational evaluation. Study participants were insulin-treated adult patients with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) from CEE. RESULTS: Most patients (85.4% T1DM and 83.6% T2DM) reported normal hypoglycemia awareness. The median hypoglycemia fear score was 5 out of 10 for T1DM and 4 out of 10 for T2DM patients. Patients increased glucose monitoring, consulted a doctor/nurse, and/or reduced the insulin dose in response to hypoglycemia. As a consequence of hypoglycemia, patients took leave from work/studies or arrived late and/or left early. Hospitalization was required for 31 (1.2%) patients with T1DM and 66 (2.1%) patients with T2DM. CONCLUSION: Hypoglycemia impacts patients' personal and social functioning, reduces productivity, and results in additional costs, both direct (related to increased use of healthcare resources) and indirect (related to absenteeism. FUNDING: Novo Nordisk.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kretowski, Adam $u Department of Endocrinology, Diabetology and Internal Diseases, Medical University of Białystok, Białystok, Poland.
700    1_
$a Strojek, Krzysztof $u Department of Internal Diseases Diabetology and Cardiometabolic Diseases, School of Medicine with the Division of Dentistry (SMDZ) in Zabrze, Medical University of Silesia, Katowice, Poland.
700    1_
$a Czupryniak, Leszek $u Department of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
700    1_
$a Janez, Andrej $u Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center, Ljubljana, Slovenia.
700    1_
$a Kempler, Peter $u First Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
700    1_
$a Andel, Michal $u Center for Research of Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Tankova, Tsvetalina $u Clinical Center of Endocrinology, Medical University-Sofia, Sofia, Bulgaria.
700    1_
$a Boyanov, Mihail $u Clinic of Endocrinology and Metabolism, Department of Internal Medicine, University Hospital Alexandrovska, Medical University-Sofia, Sofia, Bulgaria.
700    1_
$a Smircic Duvnjak, Lea $u Vuk Vrhovac University Clinic for Diabetes-UH Merkur, School of Medicine, University of Zagreb, Zagreb, Croatia.
700    1_
$a Madacsy, Laszlo $u First Department of Pediatrics, Faculty of Medicine, Semmelweis University Budapest, Budapest, Hungary.
700    1_
$a Tarnowska, Iwona $u Novo Nordisk Pharma, Warsaw, Poland.
700    1_
$a Zychma, Marcin $u Novo Nordisk Pharma, Warsaw, Poland.
700    1_
$a Lalic, Nebojsa $u Clinic for Endocrinology Diabetes and Metabolic Diseases, Clinical Center of Serbia (CCS), Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
773    0_
$w MED00194311 $t Diabetes therapy $x 1869-6953 $g Roč. 9, č. 2 (2018), s. 727-741
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29524189 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180405101935 $b ABA008
999    __
$a ind $b bmc $g 1287429 $s 1006756
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 9 $c 2 $d 727-741 $e 20180309 $i 1869-6953 $m Diabetes therapy $n Diabetes Ther $x MED00194311
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Možnosti archivace